Abbott Laboratories (ABT)
105.90
-0.02
(-0.02%)
USD |
NYSE |
May 03, 16:00
105.84
-0.06
(-0.06%)
After-Hours: 20:00
Abbott Laboratories Revenue (Annual): 40.11B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 40.11B |
| December 31, 2022 | 43.65B |
| December 31, 2021 | 43.08B |
| December 31, 2020 | 34.61B |
| December 31, 2019 | 31.90B |
| December 31, 2018 | 30.58B |
| December 31, 2017 | 27.39B |
| December 31, 2016 | 20.85B |
| December 31, 2015 | 20.40B |
| December 31, 2014 | 20.25B |
| December 31, 2013 | 19.66B |
| December 31, 2012 | 19.05B |
| December 31, 2011 | 21.41B |
| December 31, 2010 | 35.17B |
| December 31, 2009 | 30.76B |
| December 31, 2008 | 29.53B |
| December 31, 2007 | 25.91B |
| December 31, 2006 | 22.48B |
| December 31, 2005 | 22.34B |
| December 31, 2004 | 19.68B |
| Date | Value |
|---|---|
| December 31, 2003 | 17.28B |
| December 31, 2002 | 15.28B |
| December 31, 2001 | 16.29B |
| December 31, 2000 | 13.75B |
| December 31, 1999 | 13.18B |
| December 31, 1998 | 12.51B |
| December 31, 1997 | 11.89B |
| December 31, 1996 | 11.01B |
| December 31, 1995 | 10.01B |
| December 31, 1994 | 9.156B |
| December 31, 1993 | 8.408B |
| December 31, 1992 | 7.852B |
| December 31, 1991 | 6.877B |
| December 31, 1990 | 6.159B |
| December 31, 1989 | 5.380B |
| December 31, 1988 | 4.937B |
| December 31, 1987 | 4.388B |
| December 31, 1986 | 3.808B |
| December 31, 1985 | 3.360B |
| December 31, 1984 | 3.104B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
31.90B
Minimum
2019
43.65B
Maximum
2022
38.67B
Average
40.11B
Median
2023
Revenue (Annual) Benchmarks
| Stryker Corp | 20.50B |
| Boston Scientific Corp | 14.24B |
| Insulet Corp | 1.697B |
| Intuitive Surgical Inc | 7.124B |
| Edwards Lifesciences Corp | 6.005B |